Company Filing History:
Years Active: 1994-2005
Title: Keiji Wada: Innovator in Neuronal Nicotinic Acetylcholine Receptor Research
Introduction
Keiji Wada is a prominent inventor based in Rockville, MD (US), known for his significant contributions to the field of neuroscience. He holds a total of four patents, focusing on neuronal nicotinic acetylcholine receptors, which play a crucial role in various neurological functions.
Latest Patents
Wada's latest patents include innovative compositions of neuronal nicotinic acetylcholine receptors. These inventions relate to a family of receptors comprised of both neuronal agonist and non-agonist binding subunits, along with DNA sequences encoding these subunits. The novel receptor subunits include agonist binding subunits alpha2, alpha3, alpha4, and alpha5, as well as non-agonist binding subunits beta2, beta3, and beta4. Representative cDNA clones containing the DNA sequences of these inventions have been deposited with the American Type Culture Collection for patent purposes.
Career Highlights
Keiji Wada is affiliated with the Salk Institute for Biological Studies, where he conducts groundbreaking research in the field of biology and neuroscience. His work has contributed to a deeper understanding of neuronal functions and the mechanisms underlying various neurological conditions.
Collaborations
Wada has collaborated with notable colleagues, including Stephen Fox Heinemann and James Warner Patrick, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Keiji Wada's innovative work in neuronal nicotinic acetylcholine receptor research has made significant strides in neuroscience. His patents reflect a commitment to advancing our understanding of neuronal functions and their implications for health and disease.